Principal Financial Group’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-13,668
Closed -$44.8K 2290
2024
Q2
$44.8K Sell
13,668
-10,208
-43% -$44.7K ﹤0.01% 2294
2024
Q1
$175K Sell
23,876
-2,911
-11% -$18K ﹤0.01% 2195
2023
Q4
$100K Sell
26,787
-1,745
-6% -$4.12K ﹤0.01% 2274
2023
Q3
$60.5K Buy
28,532
+2,897
+11% +$9.6K ﹤0.01% 2337
2023
Q2
$122K Buy
25,635
+2,685
+12% +$14.8K ﹤0.01% 2259
2023
Q1
$131K Sell
22,950
-1,716
-7% -$10.4K ﹤0.01% 2255
2022
Q4
$249K Buy
24,666
+1,416
+6% +$26.6K ﹤0.01% 2145
2022
Q3
$521K Sell
23,250
-465
-2% -$13.4K ﹤0.01% 1952
2022
Q2
$588K Sell
23,715
-2,053
-8% -$56.6K ﹤0.01% 2019
2022
Q1
$999K Sell
25,768
-43,891
-63% -$1.7M ﹤0.01% 1974
2021
Q4
$4.08M Sell
69,659
-10,605
-13% -$601K ﹤0.01% 1736
2021
Q3
$4.76M Sell
80,264
-85,670
-52% -$6.72M ﹤0.01% 1705
2021
Q2
$14.4M Sell
165,934
-47,652
-22% -$3.84M 0.01% 1221
2021
Q1
$17.6M Buy
213,586
+177,510
+492% +$17M 0.01% 1026
2020
Q4
$3.28M Buy
36,076
+9,227
+34% +$573K ﹤0.01% 1686
2020
Q3
$1.07M Buy
26,849
+69
+0.3% +$2.41K ﹤0.01% 1858
2020
Q2
$919K Buy
26,780
+16,816
+169% +$501K ﹤0.01% 1851
2020
Q1
$221K Buy
+9,964
New +$252K ﹤0.01% 2044
2019
Q4
Sell
-10,225
Closed -$159K 2242
2019
Q3
$159K Buy
10,225
+312
+3% +$5.98K ﹤0.01% 2158
2019
Q2
$201K Buy
+9,913
New +$179K ﹤0.01% 2145
2016
Q2
Sell
-293,900
Closed -$529K 2179
2016
Q1
$529K Sell
293,900
-56,900
-16% -$117K ﹤0.01% 1824
2015
Q4
$1.18M Hold
350,800
﹤0.01% 1728
2015
Q3
$1.87M Buy
350,800
+800
+0.2% +$5.46K ﹤0.01% 1660
2015
Q2
$2.27M Buy
350,000
+140,400
+67% +$840K ﹤0.01% 1657
2015
Q1
$1.02M Buy
209,600
+1,900
+0.9% +$9.42K ﹤0.01% 1765
2014
Q4
$1.04M Buy
207,700
+4,600
+2% +$20.3K ﹤0.01% 1789
2014
Q3
$1.04M Sell
203,100
-900
-0.4% -$5.21K ﹤0.01% 1759
2014
Q2
$1.29M Hold
204,000
﹤0.01% 1758
2014
Q1
$1.99M Buy
204,000
+2,100
+1% +$16.2K ﹤0.01% 1655
2013
Q4
$1.27M Buy
+201,900
New +$1.27M ﹤0.01% 1745

Other funds holding FATE